돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 69131생성일: 2026년 10월 23일

N-(2-Aminoethyl)piperidine → 7-methyl-4-oxo-N-[2-(piperidin-1-yl)ethyl]-1-(tetrahydro-2H-pyran-4-yl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline-8-carboxamide

https://huagongshe.com/ko/reaction/69131

반응식

참여 물질

역할이름HCID투입량
반응물N-(2-Aminoethyl)piperidineHCID 33944—
반응물DiisopropylethylamineHCID 81531—
반응물Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 9886157—
반응물7-methyl-4-oxo-1-(tetrahydro-2H-pyran-4-yl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline-8-carboxylic acidHCID 136336854—
용매DimethylformamideHCID 6228—
생성물7-methyl-4-oxo-N-[2-(piperidin-1-yl)ethyl]-1-(tetrahydro-2H-pyran-4-yl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline-8-carboxamideHCID 13633686032.8%

반응 단계

To a mixture of 8.2 mg of 7-methyl-4-oxo-1-(tetrahydro-2H-pyran-4-yl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline-8-carboxylic acid, 3.8 mg of 1-(2-aminoethyl)piperidine, 13.1 μL of DIPEA, and 0.4 mL of DMF was added a mixture of 9.8 mg of HATU and 0.1 mL of DMF, followed by stirring at room temperature overnight. The reaction mixture was purified by preparative HPLC (methanol/0.1% aqueous formic acid solution) to obtain 3.6 mg of 7-methyl-4-oxo-N-[2-(piperidin-1-yl)ethyl]-1-(tetrahydro-2H-pyran-4-yl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline-8-carboxamide.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08822448B2
출처 데이터셋uspto-grants-2014_09
ORD IDord-2ba3deb513e642d98cbf40b78e3620ce
출처 메모uspto-grants-2014_09